Cyprus vs Egypt: Cause of death, by non-communicable diseases, ages 5-14, male
Cyprus
44.7%
in 2021
Egypt
43.6%
in 2021
Cyprus rank
61st
Egypt rank
63rd
Cause of death, by non-communicable diseases, ages 5-14, male over time
- Cyprus
- Egypt
How they compare
Cyprus currently reports 44.7% against 43.6% in Egypt, a difference of 1.1%.
Across all 6 years both countries report, Cyprus has been ahead every year.
Cyprus ranks 61st and Egypt ranks 63rd of 185 countries.
Cyprus has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cyprus | Egypt | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 59.3% | 42.3% | 17.0% | Cyprus |
| 2010s | 79.6% | 45.7% | 33.9% | Cyprus |
| 2020s | 64.9% | 44.8% | 20.1% | Cyprus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, male, Cyprus or Egypt?
- Cyprus, at 44.7% against 43.6% in Egypt as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, male between Cyprus and Egypt?
- 1.1%, with Cyprus ahead.
- How many years of comparable data are there for Cyprus and Egypt?
- 6 years are reported by both, from 2000 to 2021.
- How do Cyprus and Egypt rank globally for cause of death, by non-communicable diseases, ages 5-14, male?
- Cyprus ranks 61st and Egypt ranks 63rd of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, male (% of total male deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 5-14 due to non-communicable diseases divided by number of all male deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.